171 related articles for article (PubMed ID: 34663310)
1. TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination.
Jiang CF; Xie YX; Qian YC; Wang M; Liu LZ; Shu YQ; Bai XM; Jiang BH
Cancer Cell Int; 2021 Oct; 21(1):542. PubMed ID: 34663310
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane Targets the TBX15/KIF2C Pathway to Repress Glycolysis and Cell Proliferation in Gastric Carcinoma Cells.
Gu P; Wu LN
Nutr Cancer; 2023; 75(4):1263-1270. PubMed ID: 37139873
[TBL] [Abstract][Full Text] [Related]
3. miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN.
Mi H; Wang X; Wang F; Li L; Zhu M; Wang N; Xiong Y; Gu Y
Eur J Pharmacol; 2018 Nov; 839():66-75. PubMed ID: 30266665
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway.
Dai H; Xu LY; Qian Q; Zhu QW; Chen WX
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273056
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
Guan X; Gu S; Yuan M; Zheng X; Wu J
Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
[TBL] [Abstract][Full Text] [Related]
6. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
[TBL] [Abstract][Full Text] [Related]
8. MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
Pan C; Wang X; Shi K; Zheng Y; Li J; Chen Y; Jin L; Pan Z
PLoS One; 2016; 11(5):e0152090. PubMed ID: 27138141
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis.
Wang Q; Liang D; Shen P; Yu Y; Yan Y; You W
Transl Oncol; 2021 Aug; 14(8):101045. PubMed ID: 34023560
[TBL] [Abstract][Full Text] [Related]
10. miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1.
Hu G; Zhao X; Wang J; Lv L; Wang C; Feng L; Shen L; Ren W
Oncol Lett; 2018 Feb; 15(2):1621-1629. PubMed ID: 29434858
[TBL] [Abstract][Full Text] [Related]
11. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating
Zhu Z; Tang G; Yan J
Exp Ther Med; 2020 Dec; 20(6):247. PubMed ID: 33178345
[TBL] [Abstract][Full Text] [Related]
13. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
14. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.
Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM
Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261
[TBL] [Abstract][Full Text] [Related]
15. MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1.
Liang L; Fu J; Wang S; Cen H; Zhang L; Mandukhail SR; Du L; Wu Q; Zhang P; Yu X
Acta Pharm Sin B; 2020 Jun; 10(6):1036-1046. PubMed ID: 32642410
[TBL] [Abstract][Full Text] [Related]
16. miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.
Du F; Yu L; Wu Y; Wang S; Yao J; Zheng X; Xie S; Zhang S; Lu X; Liu Y; Chen W
Cell Death Dis; 2019 Dec; 10(12):922. PubMed ID: 31801953
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5.
Wang ZC; Huang FZ; Xu HB; Sun JC; Wang CF
Int J Biochem Cell Biol; 2019 Jun; 111():63-71. PubMed ID: 30710750
[TBL] [Abstract][Full Text] [Related]
18. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
19. MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.
Liu C; Xing H; Guo C; Yang Z; Wang Y; Wang Y
Cell Cycle; 2019 Sep; 18(18):2215-2227. PubMed ID: 31286834
[TBL] [Abstract][Full Text] [Related]
20. Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy.
Tan Q; Wang H; Hu Y; Hu M; Li X; Aodengqimuge ; Ma Y; Wei C; Song L
Cancer Sci; 2015 Aug; 106(8):1023-32. PubMed ID: 26041409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
